STEPTRACKERPHARMACOLOGY | NEUROLOGY | HIGH-YIELD REVIEW
Opioids & Analgesics
Opioids act on μ, κ and δ receptors to block pain transmission; the testable details are which ones are partial, mixed or special, and how overdose and withdrawal look.
FOCUS ON
μ agonists (morphine, fentanyl, hydromorphone, oxycodone, methadone, meperidine, codeine, heroin): Gi → ↓ presynaptic Ca²⁺ entry, ↑ postsynaptic K⁺ efflux. Effects: analgesia, euphoria,
respiratory depression,
miosis,
constipation (no tolerance to miosis or constipation), nausea, urinary retention, pruritus (histamine), sedation.
Overdose: coma, pinpoint pupils, bradypnea →
naloxone.
Withdrawal: mydriasis, yawning, lacrimation, rhinorrhea, piloerection, diarrhea, cramps — not life-threatening in adults; treat with methadone, buprenorphine, clonidine/lofexidine.
Special:
meperidine (normeperidine seizures; serotonin syndrome with MAOI),
methadone (long t½, QT),
tramadol (↓ seizure threshold, SNRI → serotonin syndrome),
codeine (CYP2D6),
buprenorphine (partial μ; precipitates withdrawal),
butorphanol, nalbuphine (κ agonist, μ partial),
loperamide,
dextromethorphan.
Antagonists: naloxone (IV/nasal), naltrexone (oral/IM; alcohol and opioid use disorder).
Other: acetaminophen, NSAIDs, gabapentinoids, duloxetine, TCAs, capsaicin, lidocaine patch.